Home > Insider Trading > Filing (0001144204-10-036644)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1222244	Prourocare Medical Inc.	PUMD	Surgical & Medical Instruments & Apparatus (3841)	201212923

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1403679	James Robert Rudelius	1525 Lincoln Cricle Apt 401 Mcclean VA US 22102		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.00001 Par Value	Acquisiton	2010-07-01	5,469	$1.60	69,786	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.00001 Par Value	24,756	Indirect	Held by Noble Ventures, of which reporting person is the majority owner.

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock, $0.00001 Par Value	Stock options	$2.90		2014-06-12	3,000	3,000	Direct
Common Stock, $0.00001 Par Value	Stock options	$1.00		2015-08-12	1,000	1,000	Direct
Common Stock, $0.00001 Par Value	Warrants	$0.50		2012-12-31	4,000	4,000	Direct
Common Stock, $0.00001 Par Value	Warrants	$0.50		2012-12-31	2,000	2,000	Indirect
Common Stock, $0.00001 Par Value	Warrants	$1.30		2014-01-07	19,986	19,986	Direct
Common Stock, $0.00001 Par Value	Warrants	$1.30		2014-01-07	4,756	4,756	Indirect
Common Stock, $0.00001 Par Value	Stock options	$0.85		2016-03-03	20,000	20,000	Direct
Common Stock, $0.00001 Par Value	Stock options	$1.25		2016-08-11	1,000	1,000	Direct
Common Stock, $0.00001 Par Value	Stock options	$1.50		2016-09-29	30,000	30,000	Direct
Common Stock, $0.00001 Par Value	Warrants	$1.30		2012-11-12	10,000	10,000	Direct
Common Stock, $0.00001 Par Value	Warrants	$1.30		2012-11-12	10,000	10,000	Indirect
Common Stock, $0.00001 Par Value	Warrants	$1.30	2010-07-11	2013-07-11	0	0	Indirect
Cash	Promissory Note	$1.00		2010-07-11	13,000	13,000	Indirect
Common Stock, $0.00001 Par Value	Warrants	$1.30	2010-07-11	2013-07-11	0	0	Direct
Cash	Promissory Note	$1.00		2013-07-11	13,000	13,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2014-06-12	3,000	3,000	Direct
2015-08-12	1,000	1,000	Direct
2012-12-31	4,000	4,000	Direct
2012-12-31	2,000	2,000	Indirect
2014-01-07	19,986	19,986	Direct
2014-01-07	4,756	4,756	Indirect
2016-03-03	20,000	20,000	Direct
2016-08-11	1,000	1,000	Direct
2016-09-29	30,000	30,000	Direct
2012-11-12	10,000	10,000	Direct
2012-11-12	10,000	10,000	Indirect
2013-07-11	0	0	Indirect
2010-07-11	13,000	13,000	Indirect
2013-07-11	0	0	Direct
2013-07-11	13,000	13,000	Direct

Footnotes

On June 11, 2010, the Company executed a promissory note in the principal amount of $13,000 with a maturity date of December 1, 2010, with interest to accrue daily and payable in Warrants through July 10, 2010. (the "Note"). Warrants will accrue at a rate of 333.333 shares of common stock per day up to a maximum warrant coverage of 10,000 shares of common stock per $13,000 original principal amount of Notes, which equals a maximum warrant of 10,000 shares of common stock with respect to the Note. After 30 days, the Note will bear interest payable in cash and Warrants representing the accrued interest will be issued at an exercise price of $1.30.
Currently exercisable
Options shall vest on the latter of the date that the Company is cleared by the FDA to sell the ProUroScan system in the United States or the date the Company closes on an aggregate of $2,000,000 or more of incremental equity financing after the date of grant (including the exercise of existing warrants).
Issued to reporting person in lieu of cash for director's fees.